文献速递妇科

妇科手术局部止血剂与盆腔感染风险

Topical Hemostatic Agents and the Risk of Pelvic Infection in Gynecologic Surgery.
PubMed 文献 · J Minim Invasive Gynecol · 2026-02-23

回顾性队列研究纳入2009至2019年3206例良性妇科手术,比较不同止血剂术后6周盆腔感染风险。

要点

  • 生物止血剂感染率低于机械剂和联合剂
  • 吸收性明胶海绵与最高感染风险相关
  • 腹腔镜、机器人和子宫切除术感染风险较低

核心结论

  • 谨慎使用止血剂可能降低盆腔感染风险,机械剂和联合剂风险高于生物制剂,吸收性明胶海绵可能风险更高。

研究设计与样本

  • 回顾性队列研究,纳入2009至2019年大型中西部医院3206例使用止血剂的良性妇科手术,排除小于18岁、妊娠、凝血病、恶性肿瘤或血浆过敏者。

主要发现

  • 3206例手术中生物制剂最常用(54.7%),其次机械剂(41.7%)和联合剂(3.6%)。
  • 调整后腹腔镜、机器人和子宫切除术感染 odds 低于开腹和非子宫切除术,手术时间独立相关。

临床怎么用

  • 妇科手术选择止血剂时应考虑感染风险,生物制剂可能优于机械剂和联合剂,吸收性明胶海绵需谨慎使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: As hemostatic agent use becomes routine, adverse effects must be assessed, including infection. This study compared pelvic infection after the use of different hemostatic agents. DESIGN: Pelvic infection within 6 weeks of surgery was assessed in a retrospective cohort study, with a subanalysis for hysterectomies. Fisher's exact test was used to compare cases. SETTING: This study was conducted at a large midwestern hospital. PATIENTS: Patients who underwent benign gynecologic surgeries where a hemostatic agent was used from 2009 to 2019, excluding those who were younger than 18 years, were pregnant, had coagulopathies, had malignancies, or had plasma allergies. INTERVENTIONS: This study evaluates benign gynecologic surgeries with hemostatic agent use. MEASUREMENTS AND MAIN RESULTS: Among 3206 surgeries, biologic agents were used most frequently (54.7%), followed by mechanical (41.7%) and combined agents (3.6%). Biologic agents had the lowest infection rate (0.3%) compared with mechanical (1.0%) and combined agents (1.8%; p = .023). Absorbable gelatin sponge use was associated with the highest infection rate overall (7.8% vs 0.5%; p <.001) and in hysterectomy cases (4.3% vs 0.3%; p = .003). Thrombin-fibrinogen agents were associated with lower infection rates overall (0.4% vs 1.1%; p = .018), although this was not significant in the hysterectomy subanalysis (p = .22). After adjusting for patient and surgical factors, laparoscopic, robotic, and hysterectomy procedures were associated with lower infection odds than open and nonhysterectomy approaches. Operative time was independently associated with infection. CONCLUSION: Careful use of hemostatic agents may lower infection risk. Risk appears higher with mechanical and combined agents than with biologic agents. The absorbable gelatin sponge may carry a higher risk of infection.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Mathess JM, Tursunova RHQ, Maxwell RA, et al. Topical Hemostatic Agents and the Risk of Pelvic Infection in Gynecologic Surgery. J Minim Invasive Gynecol. 2026. PMID: 41740735. doi:10.1016/j.jmig.2026.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。